Health Guide

Ozempic and Hair Loss: How Worried Should You Be? (2026)

That extra hair on the pillow a few months into Ozempic is unsettling, but it is rarely what it looks like. What most GLP-1 users notice is telogen effluvium — a shedding response set off by losing weight quickly, not by the medication attacking your follicles. Trials peg it at 3-5% of patients, with real-world numbers likely running higher. The reassuring part: it almost always reverses, and a few habits can head most of it off entirely.

Julian Caraulani
Julian Caraulani
Dr. A. Goher, MD
Medically reviewed by Dr. A. Goher, MD
Published:

The Numbers in 30 Seconds

3-5%Report Hair Loss in Trials
2.08xHigher Risk in Women (vs. Other Rx)
3-6 moTypical Shedding Duration
~100%Regrowth Rate (Temporary)

Pull the headline figures together and a clear picture emerges. When researchers tracked more than 500,000 patients in a 2025 medRxiv study, women on semaglutide were 2.08x more likely to lose hair than women on bupropion-naltrexone. Wegovy's STEP 1 trial logged 3% alopecia against 1% on placebo, jumping to 5.3% in the heaviest losers (over 20% of body weight). And the FDA's adverse-event database returns a reporting odds ratio of 2.46 for the semaglutide-alopecia pairing.

Does Ozempic Actually Cause Hair Loss?

Yes is the honest answer, but the headline misses what is really going on. Semaglutide is not a follicle toxin; nothing in how the drug works directly damages your hair. The culprit is downstream: the steep caloric deficit and fast weight loss the medication enables register as a metabolic shock, and that shock prematurely flips follicles out of their growth phase (anagen) and into the resting, soon-to-shed phase (telogen). Dermatologists have a name for that cascade — telogen effluvium.

It is the same shedding people see after weight-loss surgery, an aggressive crash diet, a difficult pregnancy, or a serious illness — any moment the body decides it is in a crisis. A 2025 systematic review in the Journal of the European Academy of Dermatology and Venereology reached the same conclusion, noting the “best described mechanism for hair loss related to these novel weight loss agents is a telogen effluvium mechanism.”

The Distinction That Matters: The Weight Loss, Not the Molecule

Cleveland Clinic, Mayo Clinic, and the dermatologists who study this all land in the same place: shedding on a GLP-1 is a knock-on effect of dropping weight fast, not a direct chemical action of semaglutide or tirzepatide. Lose the same amount the same fast way by any route and you court the same risk. The catch is that these drugs make rapid loss far easier than willpower alone, so they surface the problem more often.

How Common Is GLP-1 Hair Loss?

There is no single number, because the rate swings with which study you read, which drug you take, how high your dose climbs, and how much weight you ultimately drop. Here is how the evidence breaks down, drug by drug.

Semaglutide (Wegovy)

3% (drug) vs. 1% (placebo)

Source: STEP 1 Trial

In the Wegovy registration trial, 3% of people on semaglutide 2.4mg reported alopecia versus 1% on placebo. Zoom in on the patients who shed more than 20% of their body weight and the figure rises to 5.3%. Layer on the FDA's pharmacovigilance data, which shows a reporting odds ratio (ROR) of 2.46 for semaglutide and alopecia — those reports arrive 2.46 times more often than statistical chance would predict.

Tirzepatide (Zepbound)

Up to 5.7% at highest dose

Source: SURMOUNT-1 Trial

Tirzepatide 15mg in the SURMOUNT-1 trial saw roughly 5.7% of participants report alopecia, and FAERS pharmacovigilance returns a reporting odds ratio of 1.73 for the tirzepatide-alopecia link. The slightly steeper rate tracks with the drug's bigger average weight loss — about 22.5% versus around 15% for semaglutide — which fits the more-weight-lost, more-shedding pattern.

Real-World Data (2025-2026)

Likely higher than trial data

Source: Retrospective Cohort Studies

Outside the controlled-trial bubble the picture looks worse. A 2025 medRxiv cohort of over 500,000 patients pegged the adjusted hazard ratio for hair loss in women on semaglutide at 2.08x relative to bupropion-naltrexone users. Dermatologists speaking at the 2025-2026 AAD meetings flag everyday rates above trial figures, pinning the gap on rushed dose escalation and the thin nutritional coaching offered by many telehealth providers.

Why Hair Loss Happens on GLP-1 Medications

Once you see how the hair cycle works, both the shedding and its eventual reversal make sense. Every follicle moves through three phases on its own schedule, and rapid weight loss throws that staggered rhythm out of balance all at once.

1

Anagen (Growth Phase)

At any given moment 85-90% of your hair sits in this active growth window, and each strand can stay here for 2-7 years. The follicle is busy dividing and building new hair — work that burns real energy and leans heavily on protein, iron, and zinc.

2

Catagen (Transition)

This is the short 2-3 week off-ramp where a follicle winds down and stops producing. Normally just 1% or so of your hair occupies this stage at once. Throw the body into metabolic stress, though, and it shoves far more follicles onto this off-ramp ahead of schedule.

3

Telogen (Shedding Phase)

In a normal scalp 10-15% of hair is resting and primed to fall. Telogen effluvium drags that share up toward 30% or more all at the same time. The visible thinning then surfaces 2-4 months after the trigger, which is exactly why the shedding tends to show up well into a GLP-1 course rather than on day one.

Contributing Factors

A Steep Calorie Deficit and the Stress It Creates

Appetite drops so sharply on these drugs that many people drift down to 800-1,200 calories a day without noticing. The body reads that kind of restriction as a survival signal and quietly pulls resources from anything it deems non-essential — hair growth included. The deeper the deficit, the louder that signal and the heavier the shedding.

Running Short on Protein

Hair is essentially woven keratin, a protein, so when protein intake falls — almost inevitable when your appetite is switched off — the body rations what little it gets to vital organs first and follicles last. Plenty of GLP-1 users slip under 50 grams a day, a long way below the 0.7 to 1 gram per pound that active weight loss actually demands.

Low Iron and Zinc

Eat less food and you almost always take in fewer micronutrients. Low iron — anemia or not — is one of the most common drivers of telogen effluvium even in people who have never touched a GLP-1, and short zinc levels stall keratin production and drag out follicle recovery. Both routinely run low once portions shrink dramatically.

How Fast the Weight Comes Off

Shed more than 1 to 2 pounds a week and your telogen effluvium odds climb. At higher doses some GLP-1 users peel off 1% or more of body weight every week. The STEP 1 data spells out the trade-off plainly: 5.3% of people who lost over 20% of body weight reported hair loss, versus 2.5% of those who lost less — a textbook dose-response curve tied to how much you drop.

How to Prevent Hair Loss on GLP-1 Medications

Heading shedding off is far easier than chasing regrowth after the fact. The habits below are the ones with actual evidence behind them, and they can blunt or even prevent the loss without slowing your progress on the scale.

Eat Protein First (0.7-1g per lb)

If you only fix one thing, fix this. Target 0.7 to 1 gram of protein per pound of body weight a day — for someone at 180 pounds that is 126 to 180 grams. Lean meat, fish, eggs, Greek yogurt, cottage cheese, and shakes do the heavy lifting. Because the medication kills your appetite, the trick that works for most people is to attack the protein on your plate before anything else and lean on a whey or collagen powder to close the gap.

Plug the Nutrient Gaps

Get bloodwork first: have your doctor pull ferritin (iron stores), zinc, vitamin D, and B12. For hair to thrive, ferritin really wants to sit above 40 ng/mL. From there, biotin (2,500-5,000 mcg a day), a hair-targeted multivitamin carrying iron, zinc, and selenium, and 10-15g of collagen peptides are reasonable adds. Don't ignore vitamin D — it is low in a huge share of the population and a quiet contributor to shedding.

Climb the Dose Ladder Slowly

Ask your prescriber to draw out the titration. Rather than sprinting to the top dose, linger at each step for 6 to 8 weeks instead of the bare-minimum 4. Dermatologists at the 2025-2026 AAD meetings called out exactly this — rushing the ramp — as a leading reason real-world shedding outpaces the trial numbers. Aim for 1 to 2 pounds off per week, not 3 to 4, and you take most of the telogen effluvium risk off the table.

Don't Undereat Just Because You Can

The appetite suppression makes it dangerously easy to eat almost nothing — but try to stay above roughly 1,200 calories a day if you are a woman or 1,500 if you are a man. Drop far below that and you stack up nutrient gaps and metabolic stress fast. A loose food log is enough to confirm you are fueling hair growth while the weight still comes off. Spend those calories on nutrient-dense whole foods, not empty ones.

Keep the Water Coming

When you eat and drink less, dehydration creeps in — and it slows the delivery of nutrients to your follicles while making thinning look worse than it is. Get at least 64 ounces (2 liters) of water in daily. Staying hydrated also tames the nausea and other GI side effects these drugs cause, breaking the loop where feeling sick leads to eating even less and starving your hair further.

Be Gentle With What You Have

Styling habits won't switch off telogen effluvium, but they will keep you from making thin hair look thinner through breakage. Skip the tight ponytails, ease up on the hot tools, and put harsh chemical treatments on hold. Detangle wet hair with a wide-tooth comb, move to a sulfate-free shampoo, and if the shedding is heavy, ask about 5% minoxidil (Rogaine) — dermatologists note it can nudge the recovery phase along even when the cause is telogen effluvium.

How Long Until It Settles Down?

Telogen effluvium burns itself out — it does not keep going forever. Drawing on the clinical evidence and what dermatologists tell their patients, here is the timeline most people can expect.

Months 2-4: Shedding Begins

The first sign usually arrives 2 to 4 months after you start the drug or begin dropping weight in earnest. That lag is normal: follicles pushed into telogen need several weeks before they actually let go of the strand. In practice it shows up as more hair circling the shower drain, collecting on your pillow, or caught in your brush.

Months 4-6: Peak and Plateau

Roughly 3 to 4 months after it starts, the shedding hits its high point and then eases off as your body grows comfortable with its new weight and metabolism. People who have already patched their nutrient gaps and steadied their calorie intake tend to clear this stage faster — some are through it in as little as 6 to 8 weeks.

Months 6-12: Regrowth

After the shedding quiets, follicles slip back into the anagen growth phase and fresh hair starts pushing through. Plan on 6 to 12 months from the moment shedding stops for density to fully return. The new growth often comes in short and wispy at first, but it thickens up over time. With telogen effluvium, almost everyone gets their hair back.

When to See a Doctor

Most GLP-1 shedding is harmless telogen effluvium that wraps up on its own — but not all of it. These are the red flags that warrant a call to your dermatologist or the doctor who prescribed your medication.

The shedding hasn't let up after six months

Garden-variety telogen effluvium clears inside 3 to 6 months. If you are still losing hair past the six-month mark, something else may be at work — a lingering nutrient deficiency, a thyroid problem, or another cause that deserves a proper workup.

You're seeing bald spots, not even thinning

Telogen effluvium thins hair evenly all over; it does not carve out distinct bald patches. Patchy loss points elsewhere — alopecia areata (an autoimmune condition), a fungal infection, or another diagnosis that calls for a different treatment plan.

Thinning bad enough that scalp shows through

A little see-through thinning is par for the course, but if your scalp is clearly visible through the hair, get a dermatologist to look. A trichoscopy exam can pin down the real cause and rule out the conditions that masquerade as telogen effluvium.

The shedding comes with other symptoms

Pair hair loss with fatigue, feeling cold all the time, weight creeping up despite the medication, or brittle nails, and you may be looking at thyroid dysfunction or significant iron-deficiency anemia — both of which need bloodwork and treatment rather than patience.

It's taking a real toll on your mood

Losing hair can hit confidence and mental health hard. If the shedding is fueling anxiety or low mood, a dermatologist can walk you through active options — topical minoxidil, PRP therapy, or in some cases low-level laser therapy (LLLT) — to speed the comeback.

Frequently Asked Questions

Is the hair loss caused by the Ozempic itself, or something else?

There is no evidence that semaglutide poisons or shrinks hair follicles the way some medications do. What people experience is telogen effluvium: the body's reaction to losing weight fast and eating far less than usual. The exact same shedding shows up after bariatric surgery, postpartum, severe illness, or a crash diet. That said, the link is not imaginary — a 2025 study of more than 500,000 people found women on semaglutide carried a 2.08x higher hair-loss risk than women on bupropion-naltrexone, so the trigger is the weight loss the drug delivers rather than the molecule itself.

What are the actual odds I will lose hair on Ozempic or Wegovy?

Trial numbers land between roughly 3% and 5.3% for semaglutide. Wegovy's STEP 1 study logged 3% reporting alopecia versus 1% on placebo, and that figure climbed to 5.3% in people who shed more than 20% of their body weight. Outside controlled trials, FDA adverse-event filings and cohort studies hint the everyday rate runs higher, hitting women and anyone pushed up the dose ladder quickly the hardest.

If I do shed, is it permanent or will it come back?

For nearly everyone, it comes back. Telogen effluvium runs its course and stops on its own. As soon as your weight settles, your eating evens out, and the metabolic alarm bells quiet down, follicles flip back into their growth phase. Expect the shedding to taper within 3 to 6 months and the density to return over the following 6 to 12. Keeping protein, iron, zinc, and biotin topped up tends to shorten that recovery window.

What can I do to keep my hair while I lose weight?

Stack the deck in your favor: eat 0.7 to 1 gram of protein per pound of body weight every day, correct any iron shortfall and add zinc, biotin, and vitamin D, and ask your prescriber to climb the dose slowly so you are not dropping more than 1 to 2 pounds a week. Drink enough water and resist the urge to crash your calories just because your appetite is gone. Of all of these, the unhurried titration plan is the lever with the biggest payoff.

Do Mounjaro and Zepbound (tirzepatide) carry the same hair-loss risk?

They do. Tirzepatide shows up in both trial data and post-market reports for hair loss. An FAERS pharmacovigilance review flagged a meaningful tirzepatide-alopecia signal with a reporting odds ratio of 1.73, and Zepbound's SURMOUNT-1 trial put alopecia near 5.7% at the top dose. The story mirrors semaglutide: the rapid drop in weight, not a quirk of the drug chemistry, is what tips follicles into shedding.

Sources & References

Related Guides

Medical Disclaimer: This article is educational and is not a substitute for medical advice. Hair loss while taking a GLP-1 is usually a temporary form of shedding (telogen effluvium) tied to rapid weight loss. Talk to the doctor who prescribed your medication, or a board-certified dermatologist, before changing your supplements, adjusting your dose, or starting any hair-loss treatment. Results differ from person to person. GLP-1 Price Tracker is an independent research publication with no affiliation to Novo Nordisk, Eli Lilly, or any pharmaceutical manufacturer.